PharmaceuticalAlembic receives USFDA approval for Dexlansoprazole delayed-release capsules DRRA1 day ago01 mins Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules – Express Pharma Home Latest Updates Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules Source link Post navigation Previous: New patent policies may undermine Trump drive to lower drug pricesNext: Zydus multiple sclerosis drug Diroximel Fumarate delayed release gets tentative USFDA okay Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML DRRA2 hours ago 0